vs
INDEPENDENCE REALTY TRUST, INC.（IRT）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
INDEPENDENCE REALTY TRUST, INC.的季度营收约是再鼎医药的1.3倍（$165.3M vs $127.1M），再鼎医药同比增速更快（17.1% vs 2.5%），过去两年再鼎医药的营收复合增速更高（20.8% vs 2.2%）
独立房地产信托是一家专注于商业地产领域的不动产投资信托企业，投资布局覆盖费城、华盛顿特区以及得克萨斯州奥斯汀市的优质写字楼资产，为投资者创造稳定的不动产投资回报。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
IRT vs ZLAB — 直观对比
营收规模更大
IRT
是对方的1.3倍
$127.1M
营收增速更快
ZLAB
高出14.6%
2.5%
两年增速更快
ZLAB
近两年复合增速
2.2%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $165.3M | $127.1M |
| 净利润 | — | — |
| 毛利率 | — | 51.0% |
| 营业利润率 | — | -54.6% |
| 净利率 | — | — |
| 营收同比 | 2.5% | 17.1% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.00 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IRTZLAB
| Q1 26 | $165.3M | — | ||
| Q4 25 | $167.1M | $127.1M | ||
| Q3 25 | $167.1M | $115.4M | ||
| Q2 25 | $162.2M | $109.1M | ||
| Q1 25 | $161.2M | $105.7M | ||
| Q4 24 | $161.0M | $108.5M | ||
| Q3 24 | $160.1M | $101.8M | ||
| Q2 24 | $158.4M | $100.1M |
净利润IRTZLAB
| Q1 26 | — | — | ||
| Q4 25 | $33.3M | — | ||
| Q3 25 | $6.9M | $-36.0M | ||
| Q2 25 | $8.0M | $-40.7M | ||
| Q1 25 | $8.4M | $-48.4M | ||
| Q4 24 | $-1.0M | — | ||
| Q3 24 | $12.4M | $-41.7M | ||
| Q2 24 | $10.4M | $-80.3M |
毛利率IRTZLAB
| Q1 26 | — | — | ||
| Q4 25 | — | 51.0% | ||
| Q3 25 | — | 59.5% | ||
| Q2 25 | — | 60.6% | ||
| Q1 25 | — | 63.6% | ||
| Q4 24 | — | 61.5% | ||
| Q3 24 | — | 64.1% | ||
| Q2 24 | — | 64.9% |
营业利润率IRTZLAB
| Q1 26 | — | — | ||
| Q4 25 | — | -54.6% | ||
| Q3 25 | — | -42.3% | ||
| Q2 25 | — | -50.3% | ||
| Q1 25 | — | -53.3% | ||
| Q4 24 | — | -62.6% | ||
| Q3 24 | — | -66.6% | ||
| Q2 24 | — | -76.0% |
净利率IRTZLAB
| Q1 26 | — | — | ||
| Q4 25 | 19.9% | — | ||
| Q3 25 | 4.1% | -31.2% | ||
| Q2 25 | 5.0% | -37.3% | ||
| Q1 25 | 5.2% | -45.8% | ||
| Q4 24 | -0.6% | — | ||
| Q3 24 | 7.7% | -40.9% | ||
| Q2 24 | 6.5% | -80.2% |
每股收益（稀释后）IRTZLAB
| Q1 26 | $0.00 | — | ||
| Q4 25 | $0.14 | $-0.05 | ||
| Q3 25 | $0.03 | $-0.03 | ||
| Q2 25 | $0.03 | $-0.04 | ||
| Q1 25 | $0.04 | $-0.04 | ||
| Q4 24 | $-0.01 | $-0.09 | ||
| Q3 24 | $0.05 | $-0.04 | ||
| Q2 24 | $0.05 | $-0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $23.3M | $689.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $3.4B | $715.5M |
| 总资产 | $6.1B | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资IRTZLAB
| Q1 26 | $23.3M | — | ||
| Q4 25 | $23.6M | $689.6M | ||
| Q3 25 | $23.3M | $717.2M | ||
| Q2 25 | $19.5M | $732.2M | ||
| Q1 25 | $29.1M | $757.3M | ||
| Q4 24 | $21.2M | $779.7M | ||
| Q3 24 | $17.6M | $616.1M | ||
| Q2 24 | $21.0M | $630.0M |
总债务IRTZLAB
| Q1 26 | — | — | ||
| Q4 25 | $2.3B | — | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.2B | — | ||
| Q1 25 | $2.3B | — | ||
| Q4 24 | $2.3B | — | ||
| Q3 24 | $2.3B | — | ||
| Q2 24 | $2.3B | — |
股东权益IRTZLAB
| Q1 26 | $3.4B | — | ||
| Q4 25 | $3.5B | $715.5M | ||
| Q3 25 | $3.5B | $759.9M | ||
| Q2 25 | $3.4B | $791.7M | ||
| Q1 25 | $3.5B | $810.8M | ||
| Q4 24 | $3.4B | $840.9M | ||
| Q3 24 | $3.4B | $667.7M | ||
| Q2 24 | $3.4B | $704.2M |
总资产IRTZLAB
| Q1 26 | $6.1B | — | ||
| Q4 25 | $6.0B | $1.2B | ||
| Q3 25 | $6.1B | $1.2B | ||
| Q2 25 | $6.0B | $1.2B | ||
| Q1 25 | $6.0B | $1.2B | ||
| Q4 24 | $6.1B | $1.2B | ||
| Q3 24 | $5.9B | $985.3M | ||
| Q2 24 | $5.9B | $987.4M |
负债/权益比IRTZLAB
| Q1 26 | — | — | ||
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.66× | — | ||
| Q2 25 | 0.66× | — | ||
| Q1 25 | 0.65× | — | ||
| Q4 24 | 0.68× | — | ||
| Q3 24 | 0.68× | — | ||
| Q2 24 | 0.66× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | — | $-26.7M |
| 自由现金流率自由现金流/营收 | — | -21.0% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-158.9M |
8季度趋势，按日历期对齐
经营现金流IRTZLAB
| Q1 26 | — | — | ||
| Q4 25 | $282.1M | $-26.0M | ||
| Q3 25 | $79.3M | $-32.0M | ||
| Q2 25 | $82.2M | $-31.0M | ||
| Q1 25 | $60.4M | $-61.7M | ||
| Q4 24 | $259.8M | $-55.8M | ||
| Q3 24 | $69.2M | $-26.8M | ||
| Q2 24 | $83.0M | $-42.2M |
自由现金流IRTZLAB
| Q1 26 | — | — | ||
| Q4 25 | — | $-26.7M | ||
| Q3 25 | — | $-35.0M | ||
| Q2 25 | — | $-33.9M | ||
| Q1 25 | — | $-63.2M | ||
| Q4 24 | — | $-58.4M | ||
| Q3 24 | — | $-28.2M | ||
| Q2 24 | — | $-42.9M |
自由现金流率IRTZLAB
| Q1 26 | — | — | ||
| Q4 25 | — | -21.0% | ||
| Q3 25 | — | -30.4% | ||
| Q2 25 | — | -31.1% | ||
| Q1 25 | — | -59.9% | ||
| Q4 24 | — | -53.8% | ||
| Q3 24 | — | -27.7% | ||
| Q2 24 | — | -42.9% |
资本支出强度IRTZLAB
| Q1 26 | — | — | ||
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | 2.6% | ||
| Q2 25 | — | 2.6% | ||
| Q1 25 | — | 1.5% | ||
| Q4 24 | — | 2.4% | ||
| Q3 24 | — | 1.3% | ||
| Q2 24 | — | 0.7% |
现金转化率IRTZLAB
| Q1 26 | — | — | ||
| Q4 25 | 8.48× | — | ||
| Q3 25 | 11.51× | — | ||
| Q2 25 | 10.22× | — | ||
| Q1 25 | 7.23× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 5.60× | — | ||
| Q2 24 | 8.02× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IRT
| Rental and other property revenue | $165.2M | 100% |
| Other revenue | $109.0K | 0% |
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
